NASA Highlights Science on Next Northrop Grumman Mission to Space Station

Expedition 58 flight engineer (FE) Anne McClain performing microscope photo operations for Protein Crystal Growth 16 (PCG-16)
Expedition 58 flight engineer (FE) Anne McClain performing microscope photo operations for Protein Crystal Growth 16 (PCG-16) aboard the International Space Station.
Credits: NASA/Anne McClain

NASA will host a media teleconference at 1 p.m. EDT Wednesday, April 10, to discuss select science investigations and technology demonstrations launching on the next Northrop Grumman commercial resupply mission to theInternational Space Station.

Audio of the teleconference will be streamed live online at:

Northrop Grumman is targeting Wednesday, April 17, for the launch of its Cygnus spacecraft on an Antares rocket from pad 0A at NASAs Wallops Flight Facility in Wallops Island, Virginia.

Pete Hasbrook, associate program scientist for the International Space Station Program at NASAs Johnson Space Center in Houston, and Patrick ONeill, senior manager of marketing and communications for the stations National Lab, will provide an overview of the research and technology aboard Northrop Grummans Cygnus spacecraft.

Also participating in Wednesdays briefing are:

  • Richard L. Hughson, Schlegel Research Chair in Vascular Aging and Brain Health and senior director of research at the University of Waterloo Research Institute for Aging, will discuss theVascular Aginginvestigation, which analyzes ultrasounds of the arteries and wearable sensors of the space station crew members.
  • Roberto Piazza, professor of condensed matter physics, Polytechnic University of Milan, will discuss the Advanced Colloids Experiment-Temperature-10 (ACE-T-10) investigation, which testsgels in a microgravity environment. Knowledge gained from this investigation can be applied in efforts to grow increasingly complex materials used to build new materials and equipment in space.
  • Trevor Castor, President and CEO of Aphios Corporation, will discussTargeted Nanoparticles for Orphan and Chronic Diseasesin a Microgravity Environment Using Green SuperFluids Technology (STaARS BioScience-11) investigation. Nanosomes or nanoparticle delivery systems are being studied for use in targeting chronic diseases, such as Alzheimers and HIV. Nanoparticles created in microgravity are much smaller, enhancing drug uptake and delivery. This approach potentially reduces the required dose per treatment and decreases cost per dose.
  • Laura Shaw, International Space Station Program Lead for Exploration Life Support Systems, and John Garr, Exploration Life Support System Integrator, will discuss theThermal Amine Scrubber, a technology that tests a method to remove carbon dioxide from air aboard the orbiting outpost. NASA will use the station as the testbed to evolve the stations life support system into an evolved system for use on Gateway to support missions to the Moon and eventually for Mars missions.
  • Brian Banker,Seeker deputy project manager, will discussSeeker, a flying robot prototype to be used outside spacecraft to perform inspections. This investigation will take place after the Cygnus resupply spacecraft leaves the space station and will fly the robot on basic maneuvers to take high-resolution images of Cygnus.

To participate in the teleconference, media must contact Gina Anderson at 202-358-1100 or by 10 a.m. Tuesday, for dial-in information.

The Cygnus spacecraft will carry crew supplies, scientific research and hardware to the orbiting laboratory to support the Expedition 59 and 60 crews for the11th contracted mission by Northrop Grumman under NASAs Commercial Resupply Services contract.

For launch countdown coverage, NASA’s launch blog, and more information about the mission, visit:

/Public Release. For more details, please visit NASA website.